Determinants of treatment satisfaction of schizophrenia patients: Results from the ESPASS study

Schizophrenia Research

Volumn 139, Issue 1-3, 2012, Pages 211-217

  Nordon, Clementine ^a,b   Rouillon, Frederic ^b   Barry, Caroline ^a   Gasquet, Isabelle ^a,c   Falissard, Bruno ^a,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL PAUL BROUSSE   (France)

Author keywords

Patient related outcome; Psychosocial therapy; Schizophrenia; Second generation antipsychotics; Treatment satisfaction

Indexed keywords

AMISULPRIDE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; AGE; ARTICLE; BODY MASS; COGNITIVE THERAPY; CROSS-SECTIONAL STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMPLOYMENT STATUS; EXPECTATION; FEMALE; FRANCE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PATIENT SATISFACTION WITH PSYCHOTROPICS SELF REPORT QUESTIONNAIRE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; SCHIZOPHRENIA; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; PATIENT SATISFACTION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863785948     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.05.024     Document Type: Article

References (41)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition 1994, American Psychiatric Association, Washington DC.
2. Barak Y., Szor H., Kimhi R., Kam E., Mester R., Elizur A. Survey of patient satisfaction in adult psychiatric outpatient clinics. Eur. Psychiatry 2001, 16(2):131-133.
3. Barbui C., Nose M., Mazzi M.A., Bindman J., Leese M., Schene A., Becker T., Angermeyer M.C., Koeter M., Gray R., Tansella M. Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries. Int. Clin. Psychopharmacol. 2006, 21(2):73-79.
4. Chue P. The relationship between patient satisfaction and treatment outcomes in schizophrenia. J. Psychopharmacol. 2006, 20(6 Suppl):38-56.
5. Diez-Roux A.V. Multilevel analysis in public health research. Annu. Rev. Public Health 2000, 21:171-192.
6. Duggins R., Shaw I. Examining the concept of patient satisfaction in patients with a diagnosis of schizophrenia: a qualitative study. Psychiatrist 2006, 30:142-145.
7. Edlinger M., Hofer A., Rettenbacher M.A., Baumgartner S., Widschwendter C.G., Kemmler G., Neco N.A., Fleischhacker W.W. Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia. Schizophr. Res. 2009, 113(2-3):246-251.
8. Fong R.L., Bertakis K.D., Franks P. Association between obesity and patient satisfaction. Obesity (Silver Spring) 2006, 14(8):1402-1411.
9. Food and Drug Administration Guidance for Industry Patient-Reported Outcome Measures: use in medical product development to support labeling claims 2009.
10. Fujikawa M., Togo T., Yoshimi A., Fujita J., Nomoto M., Kamijo A., Amagai T., Uchikado H., Katsuse O., Hosojima H., Sakura Y., Furusho R., Suda A., Yamaguchi T., Hori T., Kamada A., Kondo T., Ito M., Odawara T., Hirayasu Y. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(3):755-760.
11. Gasquet I., Tcherny-Lessenot S., Lepine J.P., Falissard B. Patient satisfaction with psychotropic drugs: sensitivity to change and relationship to clinical status, quality-of-life, compliance and effectiveness of treatment. Results from a nation-wide 6-month prospective study. Eur. Psychiatry 2006, 21(8):531-538.
12. Gerber G.J., Prince P.N. Measuring client satisfaction with assertive community treatment. Psychiatr. Serv. 1999, 50(4):546-550.
13. Gharabawi G.M., Greenspan A., Rupnow M.F., Kosik-Gonzalez C., Bossie C.A., Zhu Y., Kalali A.H., Awad A.G. Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial. BMC Psychiatry 2006, 6:45.
14. Goetz I., Tohen M., Reed C., Lorenzo M., Vieta E. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord. 2007, 9(1-2):45-52.
15. Gray R., Rofail D., Allen J., Newey T. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. J. Adv. Nurs. 2005, 52(1):31-37.
16. Guy W. CGI: Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology 1976, U.S. Department of Health, Education, and Welfare, Rockville, MD.
17. Kuehn B.M. Cognitive therapy may aid patients with schizophrenia. JAMA 2011, 306(16):1749.
18. Lebow J. Pragmatic decisions in the evaluation of consumer satisfaction with mental health treatment. Eval. Program Plann. 1982, 5(4):349-356.
19. Leguay D., Cochet A., Matignon G., Hairy A., Fortassin O., Marion J.M. Social Autonomy Scale. First validation data. Encéphale 1998, 24(2):108-119.
20. Leguay D., Rouillon F., Azorin J.M., Gasquet I., Loze J.Y., Arnaud R., Dillenschneider A. Evolution of social autonomy scale in schizophrenia patients depending on their management. Encephale 2010, 36(5):397-407.
21. Lester H., Tritter J.Q., England E. Satisfaction with primary care: the perspectives of people with schizophrenia. Fam. Pract. 2003, 20(5):508-513.
22. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373(9657):31-41.
23. Limosin F., Gasquet I., Leguay D., Azorin J.M., Rouillon F. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia. Acta Psychiatr. Scand. 2008, 118(1):19-25.
24. Lincoln T.M., Lullmann E., Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr. Bull. 2007, 33(6):1324-1342.
25. Lissner L. Measuring food intake in studies of obesity. Public Health Nutr. 2002, 5(6A):889-892.
26. Mazor K.M., Clauser B.E., Field T., Yood R.A., Gurwitz J.H. A demonstration of the impact of response bias on the results of patient satisfaction surveys. Health Serv. Res. 2002, 37(5):1403-1417.
27. Miklowitz D.J., Otto M.W., Frank E., Reilly-Harrington N.A., Kogan J.N., Sachs G.S., Thase M.E., Calabrese J.R., Marangell L.B., Ostacher M.J., Patel J., Thomas M.R., Araga M., Gonzalez J.M., Wisniewski S.R. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am. J. Psychiatry 2007, 164(9):1340-1347.
28. Moller H.J. Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?. Eur. Arch. Psychiatry Clin. Neurosci. 2005, 255(3):190-201.
29. Moret L., Nguyen J.M., Volteau C., Falissard B., Lombrail P., Gasquet I. Evidence of a non-linear influence of patient age on satisfaction with hospital care. Int. J. Qual. Health Care 2007, 19(6):382-389.
30. Peyre H., Coste J., Leplege A. Identifying type and determinants of missing items in quality of life questionnaires: application to the SF-36 French version of the 2003 Decennial Health Survey. Health Qual. Life Outcomes 2010, 8(16):1-6.
31. Peyre H., Leplege A., Coste J. Missing data methods for dealing with missing items in quality of life questionnaires. A comparison by simulation of personal mean score, full information maximum likelihood, multiple imputation, and hot deck techniques applied to the SF-36 in the French 2003 decennial health survey. Qual. Life Res. 2011, 20(2):287-300.
32. Rabinowitz J., Bromet E.J., Davidson M. Short report: comparison of patient satisfaction and burden of adverse effects with novel and conventional neuroleptics: a naturalistic study. Schizophr. Bull. 2001, 27(4):597-600.
33. Ruggeri M., Lasalvia A., Bisoffi G., Thornicroft G., Vazquez-Barquero J.L., Becker T., Knapp M., Knudsen H.C., Schene A., Tansella M. Satisfaction with mental health services among people with schizophrenia in five European sites: results from the EPSILON Study. Schizophr. Bull. 2003, 29(2):229-245.
34. Salokangas R.K., Honkonen T., Stengard E., Koivisto A.M. Subjective life satisfaction and living situations of persons in Finland with long-term schizophrenia. Psychiatr. Serv. 2006, 57(3):373-381.
35. SAS Institute Inc. SAS® 9.3, Cary, NC, USA 2011.
36. Scheffer J. Dealing with missing data. Res. Lett. Inf. Math. Sci 2002, 3:153-160.
37. Tandon R., Devellis R.F., Han J., Li H., Frangou S., Dursun S., Beuzen J.N., Carson W., Corey-Lisle P.K., Falissard B., Jody D.N., Kujawa M.J., L'Italien G., Marcus R.N., McQuade R.D., Ray S., Van Peborgh P. Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder. Psychiatry Res. 2005, 136(2-3):211-221.
38. Thornicroft G., Tansella M., Becker T., Knapp M., Leese M., Schene A., Vazquez-Barquero J.L. The personal impact of schizophrenia in Europe. Schizophr. Res. 2004, 69(2-3):125-132.
39. Watanabe A., Shibata I., Kato T. Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics. Psychiatry Clin. Neurosci. 2004, 58(3):268-273.
40. Wilson-d'Almeida K., Karrow A., Bralet M.C., Bazin N., Hardy-Bayle M.C., Falissard B. In patients with schizophrenia, symptoms improvement can be uncorrelated with quality of life improvement. Eur. Psychiatry 2011, [Epub ahead of print].
41. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry 2011, 168(5):472-485.